Gast ::
| Hauptseite > Publikationsdatenbank > Engineering of natural product biosynthesis in Pseudomonas putida > print |
| Hauptseite > Publikationsdatenbank > Engineering of natural product biosynthesis in Pseudomonas putida > print |
| 001 | 888810 | ||
| 005 | 20210208142346.0 | ||
| 024 | 7 | _ | |a 10.1016/j.copbio.2020.03.007 |2 doi |
| 024 | 7 | _ | |a 0958-1669 |2 ISSN |
| 024 | 7 | _ | |a 1879-0429 |2 ISSN |
| 024 | 7 | _ | |a 2128/26883 |2 Handle |
| 024 | 7 | _ | |a altmetric:83509127 |2 altmetric |
| 024 | 7 | _ | |a 32498036 |2 pmid |
| 024 | 7 | _ | |a WOS:000589902000027 |2 WOS |
| 037 | _ | _ | |a FZJ-2020-05224 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Loeschcke, Anita |0 P:(DE-Juel1)131500 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Engineering of natural product biosynthesis in Pseudomonas putida |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2020 |b Elsevier Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1611328915_30306 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Organisms from all kingdoms of life represent a rich source for valuable natural products with various applications. Microbial systems are useful to implement the expression of respective biosynthetic genes and establish the production and effective access to natural products, or to elucidate the biochemistry of the underlying pathways. Pseudomonas putida, a Gram-negative soil bacterium, appears to be particularly suitable for natural product biosynthesis because of an advantageous intrinsic metabolism and a remarkable tolerance toward various xenobiotics. This article presents the current state of engineering P. putida for the biosynthesis of rhamnolipids, terpenoids, polyketides, non-ribosomal peptides, and products from amino acid metabolism. Technological advances facilitating chromosomal integration and expression of biosynthetic genes, and smart metabolic engineering are key to success. |
| 536 | _ | _ | |a 583 - Innovative Synergisms (POF3-583) |0 G:(DE-HGF)POF3-583 |c POF3-583 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Thies, Stephan |0 P:(DE-Juel1)128936 |b 1 |
| 773 | _ | _ | |a 10.1016/j.copbio.2020.03.007 |g Vol. 65, p. 213 - 224 |0 PERI:(DE-600)2019676-3 |p 213 - 224 |t Current opinion in biotechnology |v 65 |y 2020 |x 0958-1669 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/888810/files/Final%20Draft%20Post%20Referee-Autorenmanuskript_10.1016j.copbio.2020.03.007.pdf |y Published on 2020-06-01. Available in OpenAccess from 2021-06-01. |
| 909 | C | O | |o oai:juser.fz-juelich.de:888810 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)131500 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)128936 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Key Technologies for the Bioeconomy |1 G:(DE-HGF)POF3-580 |0 G:(DE-HGF)POF3-583 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-500 |4 G:(DE-HGF)POF |v Innovative Synergisms |x 0 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-09-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-09-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2020-09-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2020-09-05 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 |0 LIC:(DE-HGF)CCBYNCND4 |2 HGFVOC |
| 915 | _ | _ | |a Embargoed OpenAccess |0 StatID:(DE-HGF)0530 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CURR OPIN BIOTECH : 2018 |d 2020-09-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-09-05 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2020-09-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-09-05 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2020-09-05 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CURR OPIN BIOTECH : 2018 |d 2020-09-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |d 2020-09-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-09-05 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2020-09-05 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-09-05 |
| 920 | _ | _ | |l no |
| 920 | 1 | _ | |0 I:(DE-Juel1)IMET-20090612 |k IMET |l Institut für Molekulare Enzymtechnologie (HHUD) |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)IMET-20090612 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|